Protective effects of the flavonoid mixture, silymarin, on fetal rat brain and liver

被引:40
|
作者
La Grange, L [1 ]
Wang, M
Watkins, R
Ortiz, D
Sanchez, ME
Konst, J
Lee, C
Reyes, E
机构
[1] New Mexico Highlands Univ, Las Vegas, NM 87701 USA
[2] Navajo Community Coll, Tsaile, AZ USA
[3] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA
关键词
fetal alcohol syndrome; Silymarin-Phytosome (R); gamma glutamyl transpeptidase;
D O I
10.1016/S0378-8741(98)00144-5
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
We investigated the possibility that the flavonoid mixture, silymarin (SY), administered as the compound Silymarin-Phytosome(R) (PHYTO), could protect the fetus from maternally ingested EtOH. Seventy-six female rats were randomly assigned to one of seven groups: pair-fed control; chow fed control; EtOH; and four groups receiving EtOH and PHYTO in varying dosages. All groups except the chow-fed control were maintained on a liquid diet. On day 1 of pregnancy the dams began the treatment protocol. On day 21 of pregnancy the rats were sacrificed and the fetuses removed, Gamma glutamyl transpeptidase (GGTP) activity was determined for liver and brain tissue from both the fetuses and the dams. GGTP activity in the EtOH,silymarin treatment groups did nor differ significantly from that observed for the pair-fed control group. The observed GGTP activity levels for the EtOH-only group were significantly higher than those attained by the pair-fed control group. Although GGTP activity did not vary significantly with the quantity of PHYTO administered, as PHYTO dose was increased, GGTP activity decreased. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:53 / 61
页数:9
相关论文
共 50 条
  • [41] Effects of Prenatal Exposure to a Mixture of Organophosphhate Flame Ritardants on Placental Gene Expression and Serotonergic Innervaion in the Fetal Rat Brain
    Rock, Kylie D.
    St Armour, Genevieve
    Horman, Brian
    Phillips, Allison
    Ruis, Matthew
    Stewart, Allison K.
    Jima, Dereje
    Muddiman, David C.
    Stapleton, Heather M.
    Patisaul, Heather B.
    TOXICOLOGICAL SCIENCES, 2020, 176 (01) : 203 - 223
  • [42] Protective effect of silymarin on tacrolimus-induced kidney and liver toxicity
    Terzi, Funda
    Ciftci, Mustafa Kemal
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2022, 22 (01)
  • [43] Protective Effects of Luteolin on a Rat Model of Autism: An Analysis of Luteolin Flavonoid's Effects on Rat Behaviour, Histology and Cerebellar Pathology
    Mehdar, Khlood Mohammed
    Alqahtani, Saad Misfer
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2024, 20 (06)
  • [44] Protective effect of silymarin on tacrolimus-induced kidney and liver toxicity
    Funda Terzi
    Mustafa Kemal Ciftci
    BMC Complementary Medicine and Therapies, 22
  • [45] EFFECTS OF CARBON NANOTUBES ON RAT LIVER AND BRAIN
    Wang, Fu-De
    Cao, Ling-Ling
    Jin, Chan
    Liang, Hao
    Ma, Chun-Wang
    NANO, 2014, 9 (07)
  • [46] Investigation of the Protective Effects of Cannabidiol on Rat Maternal and Fetal Brain Tissues in Lipopolysaccharide-induced Pregnancy Inflammation Model
    Catakli, Deniz
    Erzurumlu, Yalcin
    Ertunc, Onur
    Sezer, Serdar
    NAMIK KEMAL MEDICAL JOURNAL, 2025, 13 (01): : 13 - 23
  • [47] EFFECTS OF NITROGLYCERIN AND ETHYLENE-GLYCOL DINITRATE MIXTURE (BLASTING OIL) ON RAT-BRAIN, LIVER AND KIDNEY
    ZITTING, A
    SAVOLAINEN, H
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1982, 37 (01): : 113 - 121
  • [48] Protective Effects of Silymarin against Doxorubicin-induced Toxicity
    Cecen, E.
    Dost, T.
    Culhaci, N.
    Karul, A.
    Ergur, B.
    Birincioglu, M.
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (10) : 2697 - 2704
  • [49] Effects of silymarin and vitamins E and C on liver damage induced by prolonged biliary obstruction in the rat
    Muriel, P
    Moreno, MG
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2004, 94 (02) : 99 - 104
  • [50] Effects of silymarin and vitamins E and C on liver damage induced by prolonged biliary obstruction in the rat
    Muriel, P
    Moreno, MG
    PHARMACOLOGY & TOXICOLOGY, 2004, 94 (02): : 99 - 104